IRCT201202159039N1
Completed
未知
Comparing the therapeutic effects of oral corticosteroid, intratympanic corticosteroid and combined approach in patients with sudden sensorineural hearing loss
ENT Research center, Tehran University of Medical Sciences0 sites150 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Idiopathic sudden sensorineural hearing loss.
- Sponsor
- ENT Research center, Tehran University of Medical Sciences
- Enrollment
- 150
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All patients with SSNHL referring to Amiralam hospital within the first 10 day of onset
- •Exclusion criteria: receiving therapy in other centers; contraindication to corticosteroid such as pregnancy, diabetus mellitus, etc; previous history of SSNHL; immunocompromised subjects; fluctuating SNHL; previous history of hydropsis; history of brain pathology or temporal bone pathology; concurrent acute or chronic otitis; VDRL\-positive cases; uncoopearte subjects; refering after 10 days.
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
A trial for comparing efficacy and safety of oral corticosteriod mini pulse versus oral tofacitinib in arresting disease progression and repigmentation of active vitiligoHealth Condition 1: L80- VitiligoCTRI/2024/04/065014Research Cell, AIIMS Jodhpur
Recruiting
Phase 3
Therapeutic Effect of Dopamine Agonist ( Dopamine ) in Comparison with Oral Contraceptives in Reducing the Size of Ovarian Benign TumorsBenign Ovarian Tumors.D27:Benign neoplasm of ovaryIRCT20180815040802N1Tabriz University of Medical Sciences40
Recruiting
Phase 3
Comparing the effectiveness of oral corticosteroids, and pineapple extract &palcebo in treating Ecchymosis and EdemaIRCT20240426061576N1Esfahan University of Medical Sciences60
Completed
Phase 3
A comparative study between the efficacy of oral Cimetidine and low dose of systemic Meglumine Antimoniate (MA) with standard dose of systemic (MA) in the treatment of syrian cutaneous leishmaniasis patients.IRCT2013123116016N1The University of Aleppo90
Recruiting
Not Applicable
A clinical trial to study the effects of two Drospirenone containing oral pills with 20 mcg and 30 mcg of ethinyl oestradiol in Polycystic ovary syndrome.Health Condition 1: null- POLYCYSTIC OVARY SYNDROMECTRI/2012/04/002571DRSUDHINDRA MOHAN BHATTACHARYA80